108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

Authors:
  • MGM.C. Garassino
    M.C. Garassino
  • JMJ. Mazieres
    J. Mazieres
  • MRM. Reck
    M. Reck
  • CCC. Chouaid
    C. Chouaid
  • HBH. Bischoff
    H. Bischoff
  • NRN. Reinmuth
    N. Reinmuth
  • LCL. Cove-Smith
    L. Cove-Smith
  • TMT. Mansy
    T. Mansy
  • DCD. Cortinovis
    D. Cortinovis
  • MMM.R. Migliorino
    M.R. Migliorino
  • ADA. Delmonte
    A. Delmonte
  • JSJ. Garcia Sánchez
    J. Garcia Sánchez

Abstract
No abstract available